G Brix1, D Nosske, U Lechel. 1. Prof. Dr. Gunnar Brix, Bundesamt für Strahlenschutz (BfS), Abteilung für medizinischen und beruflichen Strahlenschutz, Ingolstädter Landstraße 1, 85764 Oberschleissheim, Germany, Tel. +49/(0)30 18/333-23 00, Fax -23 05, E-mail: gbrix@bfs.de.
Abstract
AIM: Reinvestigation of the radiation exposure of patients undergoing whole-body [18F]FDG-PET/CT examinations pursuant to the revised recommendations of the ICRP. METHODS: Conversion coefficients for equivalent organ doses were determined for realistic anthropomorphic phantoms of reference persons. Based on these data, conversion coefficients for the effective dose were calculated using the revised tissue-weighting factors that account for the different radiation susceptibilities of organs and tissues, and the redefinition of the group 'remainder tissues'. RESULTS: Despite the markedly changed values of the equivalent organ doses estimated for FDG and of the tissue-weighting factors, the conversion coefficient for the effective dose resulting from FDG administration decreases only slightly by 10 %. For whole-body CT scans it remains even unchanged. CONCLUSION: The updated dose coefficients provide a valuable tool to easily assess the generic radiation risk of patients undergoing whole-body PET/CT (or PET/MRI) examinations and can be used, amongst others, for protocol optimization.
AIM: Reinvestigation of the radiation exposure of patients undergoing whole-body [18F]FDG-PET/CT examinations pursuant to the revised recommendations of the ICRP. METHODS: Conversion coefficients for equivalent organ doses were determined for realistic anthropomorphic phantoms of reference persons. Based on these data, conversion coefficients for the effective dose were calculated using the revised tissue-weighting factors that account for the different radiation susceptibilities of organs and tissues, and the redefinition of the group 'remainder tissues'. RESULTS: Despite the markedly changed values of the equivalent organ doses estimated for FDG and of the tissue-weighting factors, the conversion coefficient for the effective dose resulting from FDG administration decreases only slightly by 10 %. For whole-body CT scans it remains even unchanged. CONCLUSION: The updated dose coefficients provide a valuable tool to easily assess the generic radiation risk of patients undergoing whole-body PET/CT (or PET/MRI) examinations and can be used, amongst others, for protocol optimization.
Authors: Julian Kirchner; Cornelius Deuschl; Johannes Grueneisen; Ken Herrmann; Michael Forsting; Philipp Heusch; Gerald Antoch; Lale Umutlu Journal: Eur J Nucl Med Mol Imaging Date: 2017-02-04 Impact factor: 9.236
Authors: Amy N Melsaether; Roy A Raad; Akshat C Pujara; Fabio D Ponzo; Kristine M Pysarenko; Komal Jhaveri; James S Babb; Eric E Sigmund; Sungheon G Kim; Linda A Moy Journal: Radiology Date: 2016-03-29 Impact factor: 11.105
Authors: Johannes Grueneisen; Lino Morris Sawicki; Benedikt Michael Schaarschmidt; Saravanabavaan Suntharalingam; Sara von der Ropp; Axel Wetter; Verena Ruhlmann; Harald H Quick; Michael Forsting; Lale Umutlu Journal: PLoS One Date: 2016-06-21 Impact factor: 3.240
Authors: Roy A Raad; Shailee Lala; Jeffrey C Allen; James Babb; Carole Wind Mitchell; Ana M Franceschi; Kaleb Yohay; Kent P Friedman Journal: World J Nucl Med Date: 2018 Oct-Dec
Authors: Brian M Quinn; Yiming Gao; Usman Mahmood; Neeta Pandit-Taskar; Gerald Behr; Pat Zanzonico; Lawrence T Dauer Journal: BMC Med Imaging Date: 2020-01-29 Impact factor: 1.930